Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 303 | 6,998 | 2,983 | 2,689 | 4,656 |
| Cost of Goods | N/A | N/A | N/A | 2,543 | 2,715 |
| Gross Profit | 303 | 6,998 | 2,983 | 146 | 1,941 |
| Operating Expenses | 9,887 | 10,655 | 11,745 | 21,372 | 22,362 |
| Operating Income | -9,584 | -3,657 | -8,762 | -20,683 | -19,706 |
| Interest Expense | 1,107 | 1,855 | 1,922 | 2,049 | 2,592 |
| Other Income | 2,450 | 2,229 | 1,806 | 46 | 252 |
| Pre-tax Income | -8,241 | -3,283 | -8,878 | -22,686 | -22,046 |
| Net Income Continuous | -8,241 | -3,283 | -8,878 | -22,686 | -22,046 |
| Net Income Discontinuous | N/A | -7,604 | -3,756 | N/A | N/A |
| Net Income | $-8,241 | $-10,887 | $-12,634 | $-22,686 | $-22,046 |
| EPS Basic Total Ops | -697.15 | -3,099.70 | -32,601.20 | -154,235.40 | -1.28 |
| EPS Basic Continuous Ops | -697.57 | -1,038.23 | -24,501.50 | -131,259.60 | -1.28 |
| EPS Basic Discontinuous Ops | N/A | -2,057.72 | -8,099.70 | N/A | N/A |
| EPS Diluted Total Ops | -697.15 | -3,099.70 | -32,601.20 | -154,235.40 | -1.28 |
| EPS Diluted Continuous Ops | -697.57 | -1,038.23 | -24,501.50 | -131,259.60 | -1.28 |
| EPS Diluted Discontinuous Ops | N/A | -2,057.72 | -8,099.70 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -10,452.05 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-8,634 | $-2,211 | $-6,180 | $-17,825 | $-17,570 |